TELMISARTAN | A078710 | CHARTWELL RX SCIENCES LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Unichem Pharmaceuticals (USA), Inc. FDA-2025-P-7054 · 7 docket documents Unichem Pharmaceuticals (USA), Inc. filed this citizen petition requesting that the FDA determine whether MICARDIS (Telmisartan Tablets, 20 mg and 80 mg) under NDA N020850, held by Boehringer Ingelheim, was voluntarily withdrawn for safety or effectiveness reasons. The petitioner seeks confirmation | 505(q) | 2025-12-15 | Granted | Unichem Pharmaceuticals (USA), Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.1485
per ea
Lowest NADAC/Unit
$0.1070
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 62135053730TELMISARTAN 80 MG TABLET | $0.1485 | EA | Generic | — | 2026-06-17 |
| 62135053530TELMISARTAN 20 MG TABLET | $0.1070 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.